Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza in Children”

298 trials

Showing 20 of 298 results

Large-scale testing (Phase 3)UnknownNCT01040078
What this trial is testing

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Centers for Disease Control and Prevention, China 900
Large-scale testing (Phase 3)Study completedNCT01439360
What this trial is testing

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

Who this might be right for
Influenza
GlaxoSmithKline 12,046
Post-approval studies (Phase 4)Study completedNCT01196026
What this trial is testing

Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™

Who this might be right for
Influenza
GlaxoSmithKline 162
Testing effectiveness (Phase 2)Study completedNCT01625689
What this trial is testing

Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine

Who this might be right for
Influenza
PATH Vaccine Solutions 309
Post-approval studies (Phase 4)Study completedNCT00593502
What this trial is testing

Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age

Who this might be right for
Influenza
Hospital District of Southwestern Finland 409
Post-approval studies (Phase 4)Study completedNCT01069367
What this trial is testing

Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 100
Large-scale testing (Phase 3)Ended earlyNCT04544267
What this trial is testing

Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 100
Large-scale testing (Phase 3)Study completedNCT01209780
What this trial is testing

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

Who this might be right for
Seasonal Influenza
Novartis Vaccines 3,116
Large-scale testing (Phase 3)Study completedNCT01967784
What this trial is testing

Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 100
Early research (Phase 1)Study completedNCT01715909
What this trial is testing

A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

Who this might be right for
Influenza
Hoffmann-La Roche 20
Testing effectiveness (Phase 2)Study completedNCT01035749
What this trial is testing

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

Who this might be right for
Influenza
GlaxoSmithKline 310
Testing effectiveness (Phase 2)Study completedNCT00408395
What this trial is testing

Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children

Who this might be right for
Influenza
Novartis Vaccines 281
Not applicableStudy completedNCT03231995
What this trial is testing

Biomarkers for the Prognosis of Influenza in Children

Who this might be right for
Influenza
Hospices Civils de Lyon 145
Large-scale testing (Phase 3)Study completedNCT00192400
What this trial is testing

Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.

Who this might be right for
Healthy
MedImmune LLC 2,160
Post-approval studies (Phase 4)Study completedNCT02972957
What this trial is testing

Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia

Who this might be right for
Influenza
London School of Hygiene and Tropical Medicine 364
Early research (Phase 1)Study completedNCT01855945
What this trial is testing

Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.

Who this might be right for
Prophylaxis of A/H3N2v Influenza
Novartis Vaccines 627
Post-approval studies (Phase 4)Study completedNCT01001026
What this trial is testing

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults

Who this might be right for
H1N1/2009 Influenza
David Scheifele 156
Not applicableStudy completedNCT00570037
What this trial is testing

Feasibility of Cocooning Immunization Strategy With Influenza Vaccine

Who this might be right for
Influenza
Duke University 544
Testing effectiveness (Phase 2)Study completedNCT00980850
What this trial is testing

Swine Flu (Novel Influenza A H1N1) Vaccine Study

Who this might be right for
Influenza
University of Oxford 1,000
Testing effectiveness (Phase 2)Study completedNCT03698279
What this trial is testing

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 665
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation